- For Cohorts 7 and 8, subjects must have a clinical diagnosis of NAFLD and have at least one of the following criteria (a-d): a) Screening MRE with liver stiffness ≥ 4.67 kPa; b) A historical FibroScan ≥ 14 kPa within 6 months of Screening; C) Screening FibroTest® ≥ 0.75; d) A historical liver biopsy consistent with stage 4 fibrosis according to the NASH CRN classification (or equivalent)